|
AM00674PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin A [BDI517], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00675PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin A [BDI555], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00673PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin A [PCG4.1], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00673SU-N
|
OriGene Technologies
|
Clostridium difficile Toxin A [PCG4.1], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00200PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin A 5155, Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00679PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin B [B423M], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA, LF
|
|
|
AM00680PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin B [B424M], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00676PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin B [B426M], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA, LF
|
|
|
AM00677PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin B [B427M], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
AM00678PU-N
|
OriGene Technologies
|
Clostridium difficile Toxin B [B428M], Mouse Monoclonal Antibody
|
Clostridium difficile
|
ELISA
|
|
|
HY-B0975-10g
|
MedChemexpress LLC
|
Penicillin V (Potassium) [CAS 132-98-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0975-5g
|
MedChemexpress LLC
|
Penicillin V (Potassium) [CAS 132-98-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0975AS-1mg
|
MedChemexpress LLC
|
Penicillin V-d5 [CAS 1356837-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0975AS-5mg
|
MedChemexpress LLC
|
Penicillin V-d5 [CAS 1356837-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-16753-1mg
|
MedChemexpress LLC
|
Ridinilazole [CAS 308362-25-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-16753-10mg
|
MedChemexpress LLC
|
Ridinilazole [CAS 308362-25-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-16753-20mg
|
MedChemexpress LLC
|
Ridinilazole [CAS 308362-25-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-16753-5mg
|
MedChemexpress LLC
|
Ridinilazole [CAS 308362-25-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-16753-1mL
|
MedChemexpress LLC
|
Ridinilazole [CAS 308362-25-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-105099-10mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
|
HY-105099-100mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
|
HY-105099-25mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
|
HY-105099-5mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
|
HY-105099-50mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P79219-10ug
|
MedChemexpress LLC
|
Toxin B/TcdB, C. difficile (His)
|
|
|
|
